Your browser doesn't support javascript.
loading
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria).
Olivieri, A; Mancini, G; Olivieri, J; Marinelli Busilacchi, E; Cimminiello, M; Pascale, S P; Nuccorini, R; Patriarca, F; Corradini, P; Bacigalupo, A; Angelini, S; Poloni, A; Grillo, G; Onida, F; Martino, M; Di Renzo, N; Nagler, A; Mordini, N; Bruno, B; Ciceri, F; Bonifazi, F.
Afiliação
  • Olivieri A; Unit of Hematology, AUO Ospedali Riuniti di Ancona, Ancona, Italy. a.olivieri@univpm.it.
  • Mancini G; Department of Clinical and Molecular Science, Università Politecnica delle Marche, Ancona, Italy. a.olivieri@univpm.it.
  • Olivieri J; Unit of Hematology, AUO Ospedali Riuniti di Ancona, Ancona, Italy.
  • Marinelli Busilacchi E; Department of Hematology, Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
  • Cimminiello M; Department of Clinical and Molecular Science, Università Politecnica delle Marche, Ancona, Italy.
  • Pascale SP; Regional Department of Hematology, U.O.C. of Hematology and Stem Cell Transplantation, Azienda Ospedaliera Regionale San Carlo, Potenza, Italy.
  • Nuccorini R; Regional Department of Hematology, U.O.C. of Hematology and Stem Cell Transplantation, Azienda Ospedaliera Regionale San Carlo, Potenza, Italy.
  • Patriarca F; Regional Department of Hematology, U.O.C. of Hematology and Stem Cell Transplantation, Azienda Ospedaliera Regionale San Carlo, Potenza, Italy.
  • Corradini P; Department of Hematology, Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Integrata, Udine, Italy.
  • Bacigalupo A; Department of Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Angelini S; Department of Hematology, Fondazione Policlinico Universitario Gemelli IRCCS, Universita' Cattolica del Sacro Cuore, Roma, Italy.
  • Poloni A; U.O.C of Hematology, Ospedale C.G. Mazzoni, Ascoli Piceno, Italy.
  • Grillo G; Unit of Hematology, AUO Ospedali Riuniti di Ancona, Ancona, Italy.
  • Onida F; Department of Clinical and Molecular Science, Università Politecnica delle Marche, Ancona, Italy.
  • Martino M; Division of Hematology and Oncology, ASST Grande Ospedale Metropolitano Niguarda Milan, Milan, Italy.
  • Di Renzo N; BMT Center, Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Nagler A; Stem Cell Transplantation Unit (CTMO), Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.
  • Mordini N; Haematology and BMT Unit, Ospedale Vito Fazzi, Lecce, Italy.
  • Bruno B; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan, Tel Aviv University, Tel Aviv, Israel.
  • Ciceri F; BMT Center, Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Bonifazi F; S.S.D. Allogenic Stem Cell Transplantation, Department of Oncology, Presidio Molinette, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Bone Marrow Transplant ; 55(11): 2077-2086, 2020 11.
Article em En | MEDLINE | ID: mdl-32332918
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article